Evaluation of orthotopic liver transplant recipients presenting to the emergency department

Annals of Emergency Medicine

Volumn 31, Issue 4, 1998, Pages 507-517

  Savitsky, E A ^a   Uner, A B ^a   Votey, S R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; CIMETIDINE; CLARITHROMYCIN; CYCLOSPORIN A; DILTIAZEM; ERYTHROMYCIN; FLUCONAZOLE; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFCILLIN; OKT 3; PHENYTOIN; RIFAMPICIN; TACROLIMUS; THYMOCYTE ANTIBODY; VERAPAMIL;

ARTICLE; DRUG INDUCED DISEASE; EMERGENCY WARD; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; LIVER DISEASE; LIVER TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL; TREATMENT INDICATION;

EID: 0031921730     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-0644(98)70262-8     Document Type: Article

References (67)

1. TE Starzl TL Marchioro KN Von Kaulla Homotransplantation of the liver in humans Surg Gynecol Obstet 117 1963 659 676
2. S Iwatsuki TE Starzl S Todo Experience in 1,000 liver transplants under cyclosporine therapy: A survival report Transplant Proc 1 1988 498 504
3. RW Busuttil P Seu JM Millis Liver transplantation in children Ann Surg 213 1991 48 57
4. DE Eckhoff AM D'Alessandro SJ Knechtle 100 consecutive liver transplants in infants and children: An 8 year experience J Pediatr Surg 29 1994 1135 1139
5. United Network for Organ Sharing AMA News 39 1995 2
6. NIH consensus development conference statement Liver transplantation June 20-23, 1983 Hepatology 4 suppl 1984 107 110
7. TE Starzl AJ Demetris D Van Thiel Liver transplantation N Engl J Med 321 1989 1014 1022
8. S Iwatsuki BW Shaw TE Starzl Five year survival after liver transplantation Transplant Proc 17 1985 259 263
9. H Bismuth D Houssin Reduced-sized orthotopic liver graft in hepatic transplantation in children Surgery 95 1984 367 370
10. H Bismuth D Castaing JB Otte Hepatic transplantation in Europe Lancet 2 1987 674 676
11. J Quiroga I Colina AJ Demetris Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patients Hepatology 14 1991 1054 1062
12. D Kahn CO Esquivel M Madrigal-Torres An analysis of the causes of death after pediatric liver transplantation Transplant Proc 20 1988 613 661
13. BW Shaw RD Gordon S Iwatsuki Hepatic retransplantation Transplant Proc 17 1985 264 271
14. G Blumhardt B Ringe W Lauchart Vascular problems in liver transplantation Transplant Proc 19 1987 2412
15. LH Stevens JC Emond JB Piper Hepatic artery thrombosis in infants Transplantation 53 1992 396 399
16. AN Langnas W Marujo RJ Stratta Vascular complications after orthotopic liver transplantation Am J Surg 161 1991 76 83
17. J Lerut AG Tzakis K Bron Complications of venous reconstruction in human orthotopic liver transplantation Ann Surg 205 1987 404 414
18. P Legmann V Costes L Tudoret Hepatic artery thrombosis after liver transplantation: Diagnosis with spiral CT AJR Am J Roentgenol 164 1995 97 101
19. RR Lopez KG Benner K Ivancev Management of biliary complications after liver transplantation Am J Surg 163 1992 519 524
20. CW Pinson RR Lopez KG Benner Initial two year results of the Oregon liver transplant program Am J Surg 161 1991 606 611
21. RJ Stratta RP Wood AN Langnas Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation Surgery 106 1989 675 684
22. RA Evans ND Raby JG O'Grady Biliary complications following orthotopic liver transplantation Clin Radiol 41 1990 190 194
23. S Sherman P Jamidar A Shaked Biliary tract complications after orthotopic liver transplantation: Endoscopic approach to diagnosis and therapy Tranplantation 60 1995 467 470
24. RD Gordon JJ Fung B Markus The antibody crossmatch in liver transplantation Surgery 100 1986 707 715
25. G Gubernatis J Kemnitz A Bornscheuer Potential various appearances of hyperacute rejection in human liver transplantation Langenbecks Arch Chir 374 1989 240 244
26. RY Calne R. Williams Orthotopic liver transplantation: The first 60 patients BMJ 1 1977 471 476
27. JR Lowes SG Hubscher JM Neuberger Chronic rejection of the liver allograft Gastroenterol Clin North Am 22 1993 401 420
28. SG Hubscher JAC Buckels E Elias Vanishing bile duct syndrome following liver transplantation—Is it reversible Transplantion 51 1991 1004 1010
29. M Kirby P McMaster D Clements Orthotopic liver transplantation: Postoperative complications and their management Surgery 74 1987 3 11
30. DC Snover DK Freese HL Sharp Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection Am J Surg Pathol 11 1987 1 10
31. JW Williams TG Peters SR Vera Biopsy-directed immunosuppression following hepatic transplantation in man Transplantation 39 1985 589 596
32. R Williams M Smith KB Shilkin Liver transplantation in man: The frequency of rejection, biliary tract complications, and recurrences of malignancy based on an analysis of 26 cases Gastroenterology 64 1973 1026 1048
33. GBG Klintmalm JR Nery BS Husberg Rejection in liver transplantation Hepatology 10 1989 978 985
34. DK Freese DC Snover HL Sharp Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection Am J Surg Pathol 11 1987 1 10
35. DAD Wight Chronic liver transplant rejection: Definition and diagnosis Transplant Proc 28 1996 465 467
36. DK Freese DC Snover HL Sharp Chronic rejection after liver transplantation: A study of clinical, histopathological, and immunologic features Hepatology 13 1991 882 891
37. KB Noack RH Wiesner K Batts Severe ductopenic rejection with features of vanishing bile duct syndrome: Clinical, biochemical, and histologic evidence for spontaneous resolution Transplant Proc 23 1991 1448 1451
38. V Cuervas-Mons AJ Martinez A Dekker Adult liver transplantation: An analysis of the early causes of death in 40 consecutive cases Hepatology 6 1986 495 501
39. S Kusne JS Dummer N Singh Infections after liver transplantation. An analysis of 101 consecutive cases Medicine 67 1988 132 143
40. CV Paya PE Hermans JA Washington Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations Mayo Clin Proc 64 1989 555 564
41. JO Colonna DJ Winston JE Brill Infectious complications in liver transplantation Arch Surg 123 1988 360 364
42. A Corti D Sabbadini E Pannacciulli Early severe infections after orthotopic liver transplantation Transplant Proc 23 1991 1964
43. D Pillay H Charman AK Burroughs Surveillance for CMV infection in orthotopic liver transplant recipients Transplantation 53 1992 1261 1265
44. P Castaldo RJ Stratta RP Wood Clinical spectrum of fungal infections after orthotopic liver transplantation Arch Surg 126 1991 149 156
45. J Tollemar BG Ericzon K Holmberg The incidence and diagnosis of invasive fungal infections in liver transplant recipients Transplant Proc 22 1990 242 244
46. RJ Stratta MS Shaefer RS Markin Clinical patterns of cytomegalovirus disease after liver transplantation Arch Surg 124 1989 1443 1450
47. RH Wiesner E Marin MK Porayko Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation Gastroenterol Clin North Am 22 1993 351 365
48. J Hart RW Busuttil KJ Lewin Disease recurrence following liver transplantation Am J Surg Pathol 14 1990 79 91
49. JG O'Grady HM Smith SE Davies Hepatitis B virus reinfection after orthotopic liver transplantation J Hepatol 14 1992 104 111
50. JA McDonald CR Dunstan P Dilworth Bone loss after liver transplantation Hepatology 14 1991 613 619
51. MK Porayko RH Wiesner JE Hay Bone disease in liver transplant recipients: Incidence, timing, and risk factors Transplant Proc 23 1991 1462 1465
52. EB Haagsma CJP Thijn JG Post Bone disease after orthotopic liver transplantation J Hepatol 6 1988 94 100
53. JE Hay Bone disease in liver transplant recipients Gastroenterol Clin North Am 22 1993 337 350
54. WJ Sandborn JE Hay MK Porayko Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection Hepatology 19 1994 925 932
55. J McCauley J Fung A Jain The effects of FK506 on renal function after liver transplantation Transplant Proc 22 1990 17 20
56. MK Porayko SC Textor RAF Krom Nephrotoxicity of FK506 and cyclosporine when used as primary immunosuppression in liver transplant recipients Transplant Proc 25 1993 665 668
57. RW Walker JA Brochstein Neurologic complications of immunosuppressive agents Neurol Clin 6 1988 261 278
58. C Emmons J Smith M Flanigan Cerebrospinal fluid inflammation during OKT3 therapy [letter] Lancet 2 1986 510 511
59. R Shapiro JJ Fung JP Parks The side effects of FK506 in humans Transplant Proc 22 1990 35 36
60. DH Van Thiel M Iqbal A Jain Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK506 in liver transplantation Transplant Proc 22 1990 37 40
61. HC Ramos J Reyes K Abu-Elmagd Weaning of immunosuppression in long-term liver transplant recipients Transplantation 59 1995 212 217
62. S Iwatsuki TE Starzl CO Gordon Late mortality and morbidity after liver transplantation Transplant Proc 19 1987 2373 2377
63. S Iwatsuki RD Gordon BW Shaw Role of liver transplantation in cancer therapy Ann Surg 202 1985 401 407
64. C Boitard JF Bach Long-term complications of conventional immunosuppressive treatment Adv Nephrol 18 1989 335 354
65. TE Starzl KA Porter S Iwatsuki Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine therapy Lancet 1 1984 583 587
66. I Penn Cancers following cyclosporine therapy Transplantation 43 1987 32 35
67. A Eid R Steffen MK Porayko Beyond 1 year after liver transplantation Mayo Clin Proc 64 1989 446 450